pharmaceutical industryThe Big StoryBlood, Lies, and a Drug Trials Lab Gone BadBy Brendan I. KoernerScienceBetter Data on Ivermectin Is Finally on Its WayBy Adam RogersScienceThe US Is Getting Covid Booster Shots. The World Is FuriousBy Maryn McKennaScienceThe FDA OKs an Extra Vaccine Dose for Immunosuppressed PeopleBy Maryn McKennaScienceThe Drug Trial That Could Actually Produce Covid TreatmentsBy Adam RogersScienceThe Yankees Covid Outbreak May Be Bad News for Ditching MasksBy Adam RogersScienceUS Teens Can Get Their Covid Shot. What’s Next for Schools?By Gregory BarberScienceThe Statistical Secrets of Covid-19 VaccinesBy Adam RogersSciencePausing the J&J Vaccine Was Easy. Unpausing Will Be HardBy Adam RogersScienceThe US Has 3 Covid Vaccines—Testing New Ones Is ComplicatedBy Jared WhitlockScienceWhat Will it Take to Make Covid-19 Vaccines Variant-Proof?By Megan MolteniThe Big StoryMay I Borrow Your Covid Immunity?By Roxanne KhamsiScienceAre Mass Clinics the Solution for Covid-19 Vaccination?By Maryn McKennaScienceThe Covid-19 Vaccine Rollout Faces a Two-Shot ProblemBy Maryn McKennaIdeasThe Race for a Covid Vaccine Was More About Luck Than TechBy Hilda BastianScienceVaccines Are Here. We Have to Talk About Side EffectsBy Maryn McKennaScienceThe FDA's Green Light for a Vaccine Might Tank Ongoing TrialsBy Megan MolteniScienceDoes the AstraZeneca Vaccine Also Stop Covid Transmission?By Adam RogersIdeasThe AstraZeneca Covid Vaccine Data Isn't Up to SnuffBy Hilda BastianScienceHow a Medication for OCD Ended Up in a Covid-19 TrialBy Esther LandhuisScienceWe’ll Need More Than One Vaccine to Beat the PandemicBy Adam RogersScienceWinning Trust for a Vaccine Means Confronting Medical RacismBy Maryn McKennaScienceThese Oceanographers Want to Turn Marine Slime Into DrugsBy Eric NiilerScienceWhat Does It Mean If a Vaccine Is ‘Successful’?By Adam RogersMore Stories
